Ceredex Value Advisors LLC Increases Stake in Humana Inc. (NYSE:HUM)

Ceredex Value Advisors LLC raised its holdings in Humana Inc. (NYSE:HUM) by 21.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 360,374 shares of the insurance provider’s stock after acquiring an additional 64,118 shares during the quarter. Humana comprises 2.2% of Ceredex Value Advisors LLC’s portfolio, making the stock its 2nd largest position. Ceredex Value Advisors LLC owned approximately 0.30% of Humana worth $114,462,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Swedbank AB boosted its stake in Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after acquiring an additional 3,085 shares during the last quarter. Heritage Oak Wealth Advisors LLC bought a new position in shares of Humana during the second quarter worth $3,456,000. Mandatum Life Insurance Co Ltd boosted its position in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after purchasing an additional 7,500 shares in the last quarter. APG Asset Management US Inc. boosted its position in shares of Humana by 3.0% during the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after purchasing an additional 1,955 shares in the last quarter. Finally, Sei Investments Co. boosted its position in shares of Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after purchasing an additional 264 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent analyst reports. Barclays lifted their price target on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price objective on shares of Humana in a report on Tuesday, October 1st. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $519.00 to $253.00 in a report on Monday, October 7th. KeyCorp assumed coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $315.48.

Humana Stock Up 1.1 %

Humana stock opened at $260.71 on Friday. The firm has a market capitalization of $31.39 billion, a PE ratio of 23.09, a P/E/G ratio of 2.07 and a beta of 0.50. The company’s 50-day moving average is $297.06 and its 200-day moving average is $334.38. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.66.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.36%. Humana’s dividend payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.